Patent · US Active

Compositions and methods for the treatment of macular degeneration

US12097188B2 · kind B2 · utility

1Cited by
84References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 1, 2023
Grant dateSep 24, 2024
Priority date
Expiry dateSep 1, 2043

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P27/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to topical ophthalmic compositions of a lipophilic compound and an oligomeric or polymeric carrier wherein the compositions are useful in the treatment and prevention of macular degeneration. The invention also includes methods of treating macular degeneration by using a topical ophthalmic composition of a lipophilic compound and an oligomeric or polymeric carrier.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.